Delivery Order SPE2DB20D1100-SPE2DB25FA5G9

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply a medication called BRIVIACT 10 MG/ML ORAL SOLN 300ML. The contract has a ceiling value of $1,156.02 and an ultimate completion date of July 25, 2024. It is a firm fixed-price contract and does not utilize any set-aside designation. AmerisourceBergen, through its Corporate Office division, is the prime contractor on this award,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The order is valued at $6,104.90 and has a delivery deadline of October 15, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The contract has a firm fixed price of $2,275.95 and a period of performance through April 26, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This is a $1,517.16 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a range of medical commodities to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, and has a ceiling value of $2,059.06. The contract is a firm fixed price Indefinite Delivery Contract (IDC) that runs through February 2025. The contract does not have a set-aside designation, indicating it was...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The firm-fixed-price contract, valued at $1,705.58, has an ultimate completion date of August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,410.70 and a period of performance through December 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the...
This is a $4,675.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The order has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a medication, with a ceiling value of $1,305.85 and a completion date of January 29, 2025. The contract is a firm fixed-price, indefinite delivery type with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,579.87 and is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a period of performance through January 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA5G9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The contract has a ceiling value of $2,922.75 and runs through February 11, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 10:40 AM